-
*Angela Dispenzieri, MD Diagnosis and Treatment of Light-Chain Amyloidosis We will discuss the recognition, diagnosis, prognosis, and treatment of AL amyloidosis. This session should facilitate recognition of red flags of AL amyloidosis and provide physicians with the tools to differentiate AL amyloidosis from other types of amyloidosis. 1 AMA PRA Category 1 Credit ™
-
*Frederick L. Ruberg, MD Cardiac Amyloidosis for the Practicing Internist Cardiac amyloidosis is an under-diagnosed cause of congestive heart failure that now has specific approved therapies. This presentation will review aspects of epidemiology and clinical presentation while reviewing the diagnostic approach tailored to the considerations of the practicing general internist. 1 AMA PRA Category 1 Credit ™
-
*Thomas H. Brannagan, III, MD Hereditary Transthyretin Amyloid Polyneuropathy This course will describe the clinical features of hereditary ttr amyloid polyneuropathy, clues to diagnosis and new and developing treatments. 1 AMA PRA Category 1 Credit ™
-
*Marinos Dalakas, MD Significance of Amyloid deposits in Muscle: Experience from TTR Amyloid Neuropathy and Inclusion Body Myositis This course will discuss the significance of finding amyloid deposits in the muscle biopsies of patients with various myopathies or neuropathies. We will elaborate on whether there is such a diagnosis as “amyloid myopathy” and discuss the role of inflammatory mediators and various cytokines in promoting amyloid in muscle tissue and any therapeutic implications. 1 AMA PRA Category 1 Credit ™
-
*Amanda C. Peltier, MD Amyloidosis: Where Hearts and Nerves Meet We will discuss typical autonomic disfunction associated with amyloidosis, as well as testing and treatment of autonomic disfunction and how it can be used to diagnose amyloidosis. 1 AMA PRA Category 1 Credit ™
-
*John Berk, MD The Genetics of ATTR Amyloidosis This talk explores the Mendelian genetics of disease transmission, disease penetrance, geographic distributions of disease, neurologic presentations, timing and ramifications of genetic inquiry, and management of genetic carriers. 1 AMA PRA Category 1 Credit ™
-
*Rebecca E. Traub, MD Neuropathic Pain in Amyloidosis This presentation will review the causes of pain in TTR and AL amyloidosis. Medications used to treatment neuropathic pain in amyloidosis will be reviewed. Non-medication pain treatment modalities will also be discussed. 1 AMA PRA Category 1 Credit ™
